Skip to main content

Table 1 Comparison of baseline characteristics of patients with pulmonary Mycobacterium avium complex disease between the control and levofloxacin (LVFX) groups

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Characteristics

Control group (n = 57)

VFX group (n = 18)

Gender (male/female)

15/42

1/17

Age (years)

71.0 ± 7.0

64.5 ± 6.5

M.avium/M.intracellulare

51/9

16/2

Culture examination score

1.04 ± 0.38

1.06 ± 0.64

Other medication

35 (61)

11 (61)

   Digestive organ agents

30 (53)

5 (28)

   Respiratory organ agents

15 (26)

6 (33)

   Vitamins

4 ( 7 )

2 (11)

   Allergic agents

4 ( 7 )

1 ( 1 )

   Cardiovascular agents

4 ( 7 )

0 ( 0 )

   Anti-inflammatory agents

3 ( 5 )

2 (11)

   Hypnotics and sedatives, anxiolytics

3 ( 5 )

0 ( 0 )

   Miscellaneous

2 ( 4 )

0 ( 0 )

  1. The results are shown as median ± quartile deviation in age, and mean ± standard deviation in culture examination score. Values in other medication express as number (%) of patients. There was no significant difference for each characteristic between both groups